An Isotoxic Planning Comparison Study for Stage II-III Non-small Cell Lung Cancer: Is Intensity-modulated Radiotherapy the Answer?
Affiliation
Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UKIssue Date
2014-05-01
Metadata
Show full item recordAbstract
Recent clinical series suggest that treating patients with isotoxic twice-daily radiotherapy may be beneficial. This dosimetric planning study compared the use of intensity-modulated radiotherapy (IMRT) and three-dimensional conformal radiotherapy (3DRT) to deliver isotoxic treatment for non-small cell lung cancer (NSCLC) patients.Citation
An Isotoxic Planning Comparison Study for Stage II-III Non-small Cell Lung Cancer: Is Intensity-modulated Radiotherapy the Answer? 2014: Clin OncolJournal
Clinical OncologyDOI
10.1016/j.clon.2014.03.011PubMed ID
24793504Type
ArticleLanguage
enISSN
1433-2981ae974a485f413a2113503eed53cd6c53
10.1016/j.clon.2014.03.011